Zenotech staffers strike in India; Pfizer hires broker to sell UK site;

@FiercePharma: Lighter on sales reps, Big Pharma goes digital. Report | Follow @FiercePharma

> About 120 full-time and 30 part-time employees of Zenotech Laboratories, majority owned by Daiichi Sankyo, have gone on an "indefinite strike," claiming their salaries went unpaid last month and management has gone back on its word about marketing Zenotech products. Item | Report

> Pfizer engaged the real estate brokerage CB Richard Ellis to sell its soon-to-be-vacant, 325-acre R&D campus in Sandwich, England. Story

> Abbott Laboratories shares got a boost from news that Humira (adalimumab) hit its primary target in a late-stage trial assessing its efficacy in patients with ulcerative colitis. News

> Novartis' Votubia has won Swiss backing to treat patients with a benign brain tumor associated with tuberous sclerosis, a genetic disorder. Article

> Depomed said that Sun Pharmaceutical Industries is challenging patents on the diabetes drug Glumetza. Report

> Johnson & Johnson is back in the film game with Janssen's half-hour documentary Living with Schizophrenia: A Call for Hope and Recovery. Item

> Avanir Pharmaceuticals reported a bigger loss for its fiscal second quarter due to costs to launch the drug Nuedexta. News

> Boston Scientific's chief executive, J. Raymond Elliott, announced that he would step down at the end of 2011 after less than two years in the position, a move that shocked investors and sent the company's shares sliding. Story | Report

Biotech News

 @FierceBiotech: Can "backyard biotechs" beat Big Pharma at the development game? Report | Follow @FierceBiotech

 @JohnCFierce: This is exactly right. Scangos: "Biogen has been way too conservative, way too much like big pharma. Follow @JohnCFierce

> Arena stands by plan to short-circuit rat study for lorcaserin. Story

> Allos inks $360M Folotyn pact as cancer drug sales disappoint. Item

> Public Citizen: Lilly study excluded key data on Alzheimer's imaging agent. News

> PBM chief says soaring biotech sector will inspire M&A blitz. Report

> Naurex raises $18M for Ph2 depression program. Item

> New CEO Scangos spurs Biogen R&D renaissance in broad shakeup. Article

Drug Delivery News

> Researchers engineer self-assembling micelles for drug delivery. Report

> Aegis, Albany Medical College use pregnancy-produced protein against breast cancer. Article

> Macrophages go backpacking to deliver drugs. Item

> Upgraded T-cells take no prisoners, kill tumors. Story

Medical Device News

> Private equity firm urges FDA to investigate 3M. Report

> Medtronic taps Omar Ishrak as new CEO. Article

> Report: Medtronic makes big job cuts in diabetes unit. Story

> Edwards Lifesciences encouraged by valve system study results. Report

> FDA asks companies for studies of artificial hips. Item

And Finally... Chronic users of the painkiller acetaminophen are at a slightly increased risk for blood cancers, according to a U.S. study. Article

Suggested Articles

With tens of millions of Americans tuned into Tuesday’s presidential debate, the race for a COVID-19 vaccine took center stage in a big way.

A $300M pandemic ad campaign may be falling apart as HHS employees push back, celebrities balk and agency brass push a rushed timeline, Politico says.

With a pack of drugmakers angling for COVID-19 vaccine approvals in the coming months, the task of global distribution is more important than ever. Wi